Overview

A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis

Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effect of ACT-774312 on the nasal polyps and will assess the safety and tolerability of ACT-774312 in the patients with bilateral nasal polyposis
Phase:
Phase 2
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.
Treatments:
Mometasone Furoate